CVE-2023-41703

Description

User ID references at mentions in document comments were not correctly sanitized. Script code could be injected to a users session when working with a malicious document. Please deploy the provided updates and patch releases. User-defined content like comments and mentions are now filtered to avoid potentially malicious content. No publicly available exploits are known.

Category

6.1
CVSS
Severity: Medium
CVSS 3.1 •
EPSS 0.34%
Vendor Advisory open-xchange.com Vendor Advisory open-xchange.com
Affected: Open-Xchange GmbH OX App Suite
Published at:
Updated at:

References

Link Tags
https://software.open-xchange.com/products/appsuite/doc/Release_Notes_for_Patch_Release_6259_7.10.6_2023-12-11.pdf release notes vendor advisory
https://documentation.open-xchange.com/appsuite/security/advisories/csaf/2023/oxas-adv-2023-0007.json vendor advisory

Frequently Asked Questions

What is the severity of CVE-2023-41703?
CVE-2023-41703 has been scored as a medium severity vulnerability.
How to fix CVE-2023-41703?
To fix CVE-2023-41703, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2023-41703 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2023-41703 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2023-41703?
CVE-2023-41703 affects Open-Xchange GmbH OX App Suite.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.